3SBio Company Profile (NASDAQ:SSRX)

About 3SBio (NASDAQ:SSRX)

3SBio logo3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SSRX
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for 3SBio (NASDAQ:SSRX)

What is 3SBio's stock symbol?

3SBio trades on the NASDAQ under the ticker symbol "SSRX."

How were 3SBio's earnings last quarter?

3SBio Inc (NASDAQ:SSRX) issued its quarterly earnings results on Monday, March, 18th. The company reported $0.12 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.02. The company had revenue of $26.30 million for the quarter, compared to analyst estimates of $25.63 million. View 3SBio's Earnings History.

Who are some of 3SBio's key competitors?

How do I buy 3SBio stock?

Shares of 3SBio can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 3SBio's stock price today?

One share of 3SBio stock can currently be purchased for approximately $14.92.


MarketBeat Community Rating for 3SBio (NASDAQ SSRX)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for 3SBio (NASDAQ:SSRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for 3SBio (NASDAQ:SSRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/20/2017Goldman Sachs Group, Inc. (The)UpgradeNeutral -> BuyLowView Rating Details
(Data available from 9/21/2015 forward)

Earnings

Earnings History for 3SBio (NASDAQ:SSRX)
Earnings by Quarter for 3SBio (NASDAQ:SSRX)
Earnings History by Quarter for 3SBio (NASDAQ SSRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/18/2013Q4 2012$0.14$0.12$25.63 million$26.30 millionViewListenView Earnings Details
11/12/2012Q312$0.29$0.15$28.18 million$28.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for 3SBio (NASDAQ:SSRX)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for 3SBio (NASDAQ:SSRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for 3SBio (NASDAQ:SSRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for 3SBio (NASDAQ:SSRX)
Latest Headlines for 3SBio (NASDAQ:SSRX)
Source:
DateHeadline
americanbankingnews.com logo3SBio Inc (SSRX) Upgraded to Buy at Goldman Sachs Group Inc
www.americanbankingnews.com - March 20 at 12:27 PM

Social

Chart

3SBio (SSRX) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff